NEUROLOGICAL CONSEQUENCE OF INDUSTRIAL EXPOSURE TO 1-METHYL-4-PHENYL-1, 2, 3, 6-TETRAHYDROPYRIDINE
- 30 March 1985
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 325 (8431), 747
- https://doi.org/10.1016/s0140-6736(85)91278-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Trail of Ironies to Parkinson's DiseaseScience, 1984
- Chronic Parkinsonism Secondary to Intranasal Administration of a Product of Meperidine-Analogue SynthesisNew England Journal of Medicine, 1984
- Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s DiseaseCanadian Journal of Neurological Sciences, 1984
- Etiology of Parkinson’s Disease: A Research StrategyCanadian Journal of Neurological Sciences, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-TetrahydropyridineNew England Journal of Medicine, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- The Aminomethylation of Olefins. II. A New Synthesis of 1-Alkyl-4-aryl-4-piperidinolsJournal of the American Chemical Society, 1955